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68S Abstracts May Supplement 2013Objectives: To determine trends in the incidence of
amputation and mode of revascularization [endovascular
(ENDO) vs open surgical (OPEN) vs both (HYBRID)]
among persons with peripheral arterial disease (PAD) in
a deﬁned population.
Methods: A population based cohort study of resi-
dents of a single county was conducted from 1990 to
2009. Procedures were identiﬁed by ICD9/CPT codes.
Age and gender-adjusted Poisson regression analysis was
used to determine 5-year incidence trends.
Results: A total of 773 residents (mean age 68.6 yrs)
underwent 1906 limb revascularization procedures; 61%
for critical limb ischemia (CLI) and 32% for claudication
with a median of two procedures per limb. The cohort
was predominantly male (58.5%; P < .0001) and Caucasian
(96.5%). Initial ENDO procedures were more frequently
for claudication (54%) and OPEN for CLI (58%). Five-
year incidence rates showed signiﬁcant decreases in
OPEN and increases in ENDO and HYBRID revasculari-
zations over the 20-year period (P < .001; Fig). Total
revascularizations increased from 91 to 118 (P ¼ .0014)
and amputations decreased from 21 to 13/100,000
person-years (P ¼ .0123). Primary amputations decreased
from 13 to 5/100,000 person-years (P ¼ .0002).
Conclusions: In this population based study spanning
20 years, the incidence of amputations and OPEN revascu-
larizations decreased signiﬁcantly among PAD patients,
with concomitant increases in total, ENDO and HYBRID
revascularizations.Fig.Author Disclosures: T. Bower: Nothing to disclose;
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Objectives: Diabetic patients form an important chal-
lenge in treating occlusive disease of the SFA. In this study
we have evaluated the results of 327 patients treated in two
hospitals in the Netherlands over a 10-year period. These
patients were treated with an e-PTFE nitinol self-expand-
ing endograft in the SFA/popliteal region for occlusive
disease. The aim of this study is to compare the results of
patients with diabetes (DM), with patients that didn’t
have diabetes (non-DM).
Methods: Male to female ratio was 73.7 vs 26.3%.
Mean age during surgery was 69.03 years. All patients
included had clinical symptoms of Intermittend Claudica-
tion or critical Limb Ischaemia (CLI). SFA lesions of both
groups of patients were scored according to the Trans
Atlantic Inter Society Consensus (TASC II). Follow up
was done after 3, 6, and 12 months, and every year there-
after. 36.7% of patients had DM (n ¼ 120). Our objective
was to asses primary and secondary 2-year patency in both
DM patients and in non-DM patients and compared the
two. Statistical analysis was done formng Kaplan Meier
survival curves to describe patency during follow-up.
The two groups were compared using Log Rank
(Mantel-Cox) analysis. Follow up included duplex ultra-
sonography and ankle brachial indices as well as pysical
examination.
Results: No statistical differences were found between
the two groups with respect to age and TASC classiﬁcation.
TASC II classiﬁcation in DM group was TASC A/B/C/
D: 25/39/25/31 and in the non-DM group: 51/54/
37/65, P value .436 (N.S.). 2-year primary and secondary
patency was 60,8 and 90% in the DM group (n ¼ 120),
and 65.2, and 82.6% in the non-DM group (n ¼ 207).
Log-rank (mantel Cox) analysis of the two Kaplan Meier
curves showed P values of .442 and .069 (both NS).
Conclusions: 2 year primary and secondary patency
rates of DM patients were equal to that of non-DM
patients. The 2-year secondary patency of 90% in the
DM group could only be achieved with a follow up
program and subsequent intervention when needed.
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Factors Affecting Outcome After Endovascular Repair
(EVPAR) of Popliteal Artery Aneurysms (PAAs)
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Objectives: To analyze factors affecting outcome after
EVPAR.
Methods: Clinical data of consecutive PAA patients
treated with EVPAR (2000-2012) were reviewed. Primary
endpoints were major adverse events: mortality, throm-
bosis, amputation, complications, reinterventions.
